CD34 is a well-known marker for primitive and bone marrow-derived progenitor cells, especially for hematopoietic and endothelial progenitors. ZenBio offers CD34+ progenitor cells in a phenotypically undifferentiated state. The progenitor cells are derived from cord blood and bone marrow of healthy donors and produced at the ZenBio facility. Progenitor cells contain two main cellular subpopulations, hematopoietic and endothelial progenitor cells. CD34+ progenitor cells are suitable for a series of studies for directed differentiation into more committed types of blood cells and endothelial lineages. Immediately after isolation, the freshly prepared CD34+ progenitor cells are cryopreserved using a serum-free freezing medium.
Samples from each donor are tested via PCR to confirm non-reactivity.
Human Blood Progenitor Cells
|SER-CD34-F||Cryopreserved Human Cord Blood CD34/CD133+ Progenitor Cells, POOLED Donor Lot: (100,000 cells/vial)||Vial||$226.00|
|SER-CD34-1F||Normal Human Cord Blood CD34 /CD133+ Cells, Cryopreserved, SINGLE Donor, 1 million cells/vial||Vial||$1200.00|
|SER-BMCD34-F||Normal Human Bone Marrow CD34+ Cells, Cryopreserved, Single Donor, 0.5 million cells/vial||Vial||$617.00|
|LYMPH-1||Lymphocyte Medium for Thawing, Plating and Short-Term Maintenance||100ml||$100.00|
Contact Us For More Information.
Soft extracellular matrix enhances inflammatory activation of mesenchymal stromal cells to induce monocyte production and traffickingSing Wan Wong, Stephen Lenzini, Madeline H. Cooper, David J. Mooney, and Jae-Won Shin